169 related articles for article (PubMed ID: 19254362)
1. APOBEC3G mRNA expression in exposed seronegative and early stage HIV infected individuals decreases with removal of exposure and with disease progression.
Vázquez-Pérez JA; Ormsby CE; Hernández-Juan R; Torres KJ; Reyes-Terán G
Retrovirology; 2009 Mar; 6():23. PubMed ID: 19254362
[TBL] [Abstract][Full Text] [Related]
2. APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4+ T-cell counts and plasma viral load.
Reddy K; Winkler CA; Werner L; Mlisana K; Abdool Karim SS; Ndung'u T;
AIDS; 2010 Jan; 24(2):195-204. PubMed ID: 19996938
[TBL] [Abstract][Full Text] [Related]
3. Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllers.
Kikuchi T; Iwabu Y; Tada T; Kawana-Tachikawa A; Koga M; Hosoya N; Nomura S; Brumme ZL; Jessen H; Pereyra F; Trocha A; Walker BD; Iwamoto A; Tokunaga K; Miura T
J Virol; 2015 May; 89(9):4992-5001. PubMed ID: 25717111
[TBL] [Abstract][Full Text] [Related]
4. APOBEC3G levels predict rates of progression to AIDS.
Jin X; Wu H; Smith H
Retrovirology; 2007 Mar; 4():20. PubMed ID: 17374143
[TBL] [Abstract][Full Text] [Related]
5. APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+ T-cell count.
Cho SJ; Drechsler H; Burke RC; Arens MQ; Powderly W; Davidson NO
J Virol; 2006 Feb; 80(4):2069-72. PubMed ID: 16439564
[TBL] [Abstract][Full Text] [Related]
6. The level of APOBEC3G (hA3G)-related G-to-A mutations does not correlate with viral load in HIV type 1-infected individuals.
Ulenga NK; Sarr AD; Hamel D; Sankale JL; Mboup S; Kanki PJ
AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1285-90. PubMed ID: 18851679
[TBL] [Abstract][Full Text] [Related]
7. Expression analysis of LEDGF/p75, APOBEC3G, TRIM5alpha, and tetherin in a Senegalese cohort of HIV-1-exposed seronegative individuals.
Mous K; Jennes W; Camara M; Seydi M; Daneau G; Mboup S; Kestens L; Van Ostade X
PLoS One; 2012; 7(3):e33934. PubMed ID: 22479480
[TBL] [Abstract][Full Text] [Related]
8. APOBEC3G expression and hypermutation are inversely associated with human immunodeficiency virus type 1 (HIV-1) burden in vivo.
Kourteva Y; De Pasquale M; Allos T; McMunn C; D'Aquila RT
Virology; 2012 Aug; 430(1):1-9. PubMed ID: 22579353
[TBL] [Abstract][Full Text] [Related]
9. APOBEC3G/CEM15 (hA3G) mRNA levels associate inversely with human immunodeficiency virus viremia.
Jin X; Brooks A; Chen H; Bennett R; Reichman R; Smith H
J Virol; 2005 Sep; 79(17):11513-6. PubMed ID: 16103203
[TBL] [Abstract][Full Text] [Related]
10. APOBEC3G/3A Expression in Human Immunodeficiency Virus Type 1-Infected Individuals Following Initiation of Antiretroviral Therapy Containing Cenicriviroc or Efavirenz.
Covino DA; Purificato C; Catapano L; Galluzzo CM; Gauzzi MC; Vella S; Lefebvre E; Seyedkazemi S; Andreotti M; Fantuzzi L
Front Immunol; 2018; 9():1839. PubMed ID: 30135687
[TBL] [Abstract][Full Text] [Related]
11. Short Communication: Expression of APOBEC3G and Interferon Gamma in Pleural Fluid Mononuclear Cells from HIV/TB Dual Infected Subjects.
Toossi Z; Meng Q; Aung H; Liu S; Mayanja-Kizza H; Hirsch CS
AIDS Res Hum Retroviruses; 2015 Jul; 31(7):692-5. PubMed ID: 25924204
[TBL] [Abstract][Full Text] [Related]
12. Human APOBEC3G-mediated hypermutation is associated with antiretroviral therapy failure in HIV-1 subtype C-infected individuals.
Neogi U; Shet A; Sahoo PN; Bontell I; Ekstrand ML; Banerjea AC; Sonnerborg A
J Int AIDS Soc; 2013 Feb; 16(1):18472. PubMed ID: 23443042
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: a possible role in the resistance to HIV of HIV-exposed seronegative individuals.
Biasin M; Piacentini L; Lo Caputo S; Kanari Y; Magri G; Trabattoni D; Naddeo V; Lopalco L; Clivio A; Cesana E; Fasano F; Bergamaschi C; Mazzotta F; Miyazawa M; Clerici M
J Infect Dis; 2007 Apr; 195(7):960-4. PubMed ID: 17330785
[TBL] [Abstract][Full Text] [Related]
14. APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.
Krisko JF; Begum N; Baker CE; Foster JL; Garcia JV
J Virol; 2016 May; 90(9):4681-4695. PubMed ID: 26912618
[TBL] [Abstract][Full Text] [Related]
15. Intracellular detection of differential APOBEC3G, TRIM5alpha, and LEDGF/p75 protein expression in peripheral blood by flow cytometry.
Mous K; Jennes W; De Roo A; Pintelon I; Kestens L; Van Ostade X
J Immunol Methods; 2011 Sep; 372(1-2):52-64. PubMed ID: 21784078
[TBL] [Abstract][Full Text] [Related]
16. The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells.
Casartelli N; Guivel-Benhassine F; Bouziat R; Brandler S; Schwartz O; Moris A
J Exp Med; 2010 Jan; 207(1):39-49. PubMed ID: 20038599
[TBL] [Abstract][Full Text] [Related]
17. Vpr14-88-Apobec3G fusion protein is efficiently incorporated into Vif-positive HIV-1 particles and inhibits viral infection.
Ao Z; Yu Z; Wang L; Zheng Y; Yao X
PLoS One; 2008 Apr; 3(4):e1995. PubMed ID: 18414671
[TBL] [Abstract][Full Text] [Related]
18. ISG15 expression correlates with HIV-1 viral load and with factors regulating T cell response.
Scagnolari C; Monteleone K; Selvaggi C; Pierangeli A; D'Ettorre G; Mezzaroma I; Turriziani O; Gentile M; Vullo V; Antonelli G
Immunobiology; 2016 Feb; 221(2):282-90. PubMed ID: 26563749
[TBL] [Abstract][Full Text] [Related]
19. A naturally occurring Vif mutant (I107T) attenuates anti-APOBEC3G activity and HIV-1 replication.
Peng J; Ao Z; Matthews C; Wang X; Ramdahin S; Chen X; Li J; Chen L; He J; Ball B; Fowke K; Plummer F; Embree J; Yao X
J Mol Biol; 2013 Aug; 425(16):2840-52. PubMed ID: 23707381
[TBL] [Abstract][Full Text] [Related]
20. Alteration of select gene expression patterns in individuals infected with HIV-1.
Serrao E; Wang CH; Frederick T; Lee CL; Anthony P; Arribas-Layton D; Baker K; Millstein J; Kovacs A; Neamati N
J Med Virol; 2014 Apr; 86(4):678-86. PubMed ID: 24482297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
